FDA committee recommends restricting use of anti-anaemia drug in cancer.
Tanne
Janice Hopkins
JH
D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D014481:United States; D014486:United States Food and Drug Administration
D004921:Erythropoietin